Avoiding Systemic Heparinization During Hemodialysis: How the Dialysis Setup Might Help

Onderzoeksoutput: Articlepeer review


Heparin is the most widely used anticoagulant for maintaining patency of the extracorporeal blood circuit during intermittent hemodialysis. Inadvertently, this leads to systemic heparinization of the patient. Repeated intermittent heparinization during hemodialysis has been associated with increased bleeding risks and metabolic and immunologic effects. Alternative strategies for minimizing systemic anticoagulation encompass dilution methods, regional citrate anticoagulation, priming of the extracorporeal circuit, and modifications to dialyzer membranes and dialysate composition. The effectiveness of these alternatives in maintaining patency of the extracorporeal circuit varies substantially. Although most studies have focused on particular changes in the hemodialysis setup, several combined interventions for adapting the hemodialysis setup are now being studied. This narrative review aims to present an overview of the current landscape of hemodialysis setup strategies aimed at limiting or avoiding systemic anticoagulation during treatment. Additionally, this review intends to shed light on the underlying pathophysiological mechanisms that contribute to variations observed in reported outcomes.
Originele taal-2English
TijdschriftSeminars in Nephrology
StatusPublished - 13 jan 2024

Bibliografische nota

Publisher Copyright:
© 2023 Elsevier Inc.


Duik in de onderzoeksthema's van 'Avoiding Systemic Heparinization During Hemodialysis: How the Dialysis Setup Might Help'. Samen vormen ze een unieke vingerafdruk.

Citeer dit